Biogen Inc. buy BMO Capital Markets
Start price
09.11.23
/
50%
€211.40
Target price
09.11.24
€276.44
Performance (%)
-23.23%
End price
10.11.24
€162.30
Summary
This prediction ended on 10.11.24 with a price of €162.30. The price of Biogen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -23.23%. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 2.181% | 2.181% | 64.049% |
| iShares Core DAX® | 2,57 % | 3,50 % | 8,41 % |
| iShares Nasdaq 100 | 4,86 % | 0,65 % | 28,38 % |
| iShares Nikkei 225® | 5,59 % | -0,25 % | 52,92 % |
| iShares S&P 500 | 3,25 % | 2,08 % | 24,37 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at BMO Capital Markets from $314.00 to $295.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten